Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2016 · 21 citations · 19 references
MedicineMolecular BiologyOncologyCancer PharmacologyChemotherapyMolecular OncologyCancer Cell SignalingChemotherapy ResistanceCytotoxic ChemotherapyOvarian CancerSignal Transduction In CancerTherapeutic ResistanceOvarian Cancer ChemotherapyOvarian Cancer PathogenesisP21 PathwayP21 RegulationPi3k-akt Signaling PathwayPlatinum SensitivityReversal Of Drug ResistanceTherapeutic Resistance Mechanisms
Drug resistance is the leading cause of chemotherapy failure in the treatment of ovarian cancer. So far, little is known about the mechanism of chemoresistance in ovarian cancer. In this study, we explored the mechanism that HSP27 was involved in cisplatin resistance of ovarian cancer both in vitro and clinically. HSP27 protein was found to be upregulated and expressed in cisplatin-resistant ovarian cancer cell line C13*, and HSP27 siRNA transfection reversed the chemoresistance of C13*. We found that HSP27 exerted its chemoresistant role by inhibiting p21 transferring from the nucleus to the plasma through the activation of phosphorylated-Akt pathway. These findings have implications for clinical trials aimed at a potential therapeutic target for ovarian tumors that are refractory to conventional treatment.
19
The current state of two-dimensional electrophoresis with immobilized pH gradients
Angelika Görg, Christian Obermaier, Günther Boguth et al. · Electrophoresis · 2000 · 1.5K citations
Heat Shock Protein 27 Controls Apoptosis by Regulating Akt Activation
Madhavi J. Rane, Yong Pan, Saurabh Singh et al. · Journal of Biological Chemistry · 2003 · 363 citations · Full text